We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$6.97B
AUM Growth
+$4.79B
Cap. Flow
+$6.91B
Cap. Flow %
99.25%
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,370
Increased
1,985
Reduced
143
Closed
794

Sector Composition

Rank Sector Weight
1 Technology 13.48%
2 Financials 8.05%
3 Industrials 7.03%
4 Consumer Discretionary 6.62%
5 Healthcare 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNPR icon
3226
Monopar Therapeutics
MNPR
$799M
$1.14K ﹤0.01%
+14
New +$626
MKTW icon
3227
MarketWise
MKTW
$56.3M
$1.14K ﹤0.01%
+69
New +$1.26K
BOC icon
3228
Boston Omaha
BOC
$438M
$1.14K ﹤0.01%
+87
New +$1.17K
ISPR icon
3229
Ispire Technology
ISPR
$91.3M
$1.14K ﹤0.01%
+444
New +$1.29K
RNAC icon
3230
Cartesian Therapeutics
RNAC
$245M
$1.14K ﹤0.01%
+111
New +$1.25K
SKIL icon
3231
Skillsoft
SKIL
$75.4M
$1.13K ﹤0.01%
+87
New +$1.28K
LZB icon
3232
La-Z-Boy
LZB
$1.66B
$1.13K ﹤0.01%
33
-20
-38% -$733
BALY icon
3233
Bally's
BALY
$686M
$1.11K ﹤0.01%
+100
New +$1.01K
BCAX
3234
Bicara Therapeutics
BCAX
$1.7B
$1.1K ﹤0.01%
70
+11
+19% +$123
TERN
3235
DELISTED
Terns Pharmaceuticals
TERN
$1.1K ﹤0.01%
+147
New +$939
SG icon
3236
Sweetgreen
SG
$725M
$1.1K ﹤0.01%
+138
New +$1.5K
EOSE icon
3237
Eos Energy Enterprises
EOSE
$1.38B
$1.08K ﹤0.01%
+95
New +$650
NNE
3238
Nano Nuclear Energy
NNE
$960M
$1.08K ﹤0.01%
+28
New +$994
CRVS icon
3239
Corvus Pharmaceuticals
CRVS
$1.17B
$1.08K ﹤0.01%
+146
New +$747
WOW
3240
DELISTED
WideOpenWest
WOW
$1.07K ﹤0.01%
+208
New +$932
NAKA
3241
Nakamoto Inc
NAKA
$84.4M
$1.07K ﹤0.01%
25
+7
+39% +$2.22K
ECC
3242
Eagle Point Credit Company
ECC
$510M
$1.06K ﹤0.01%
160
ENLV icon
3243
Enlivex Ltd
ENLV
$36.7M
$1.06K ﹤0.01%
68
BBDO icon
3244
Banco Bradesco
BBDO
$34.8B
$1.05K ﹤0.01%
359
+1
+0.3% +$3
WNEB icon
3245
Western New England Bancorp
WNEB
$281M
$1.04K ﹤0.01%
+87
New +$991
NRIX icon
3246
Nurix Therapeutics
NRIX
$2.61B
$1.04K ﹤0.01%
+113
New +$1.17K
EVI icon
3247
EVI Industries
EVI
$180M
$1.04K ﹤0.01%
+33
New +$863
CIB icon
3248
Grupo Cibest SA
CIB
$21.4B
$1.04K ﹤0.01%
+20
New +$966
ONC
3249
BeOne Medicines Ltd
ONC
$34B
$1.02K ﹤0.01%
3
-5
-63% -$1.52K
FLL icon
3250
Full House Resorts
FLL
$80.5M
$1.02K ﹤0.01%
+318
New +$1.25K

Similar funds

Arax Advisory Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,370 new positions and adding to 1,985 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.

  • Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
  • Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
  • Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
  • Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
  • Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
  • Arax Advisory Partners opened 1,370 new positions and closed 794 in Q3 2025.
  • Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.

Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.